Abstract:N6-methyladenosine (m6A) is an epigenetic modification widely existing in tumor cells that dynamically and reversibly modifies mRNA. Ovarian cancer is the malignant tumor with the highest mortality among gynecological cancers. High or low expressions of m6A regulators may lead to the promotion or inhibition of ovarian cancer development and progression, but the specific mechanism has not been fully elucidated. Therefore, to explore the effects of m6A regulators on the progression of ovarian cancer will facilitate the early diagnosis and treatment of ovarian cancer. This review summarizes the advances in the effects of m6A regulators on proliferation and metastasis of ovarian cancer as well as the underlying mechanisms thereof in recent years.